Search terms
Results 1 - 10 of 11 - ordered by :
Pages: 1 2

(1) Their publication, say the authors, comes at a time when the risk of cardiovascular disease in pregnancy continues to rise in developed countries, mainly because of today's older age at first ...

Date : 26/08/2011

(1) The off-label use of the drug led to worse clinical outcomes including a doubled risk of hospitalisation compared to placebo. “Valvular disease is considered the next cardiac epidemic ...

Date : 28/08/2017

With stress echocardiography, we can measure the cardiovascular response during exercise in terms of cardiac function, valve function and haemodynamic function. Because of its comprehensive nature, ...

Date : 07/12/2018

Pulmonary arterial hypertension (with two subtypes: pulmonary veno-occlusive disease and/or pulmonary capillary haemangiomatosis and persistent PH of the newborn) PH due to left heart disease PH due ...

Date : 01/09/2015

Prior to the event, the patient exercised 5 times per week for 1 to 2 hours per session, cross-country skiing during winter and running and cycling during summer, and participated in official ...

Date : 06/02/2017

The Guidelines have been jointly produced by a Task Force of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS); the Task Force also included experts from the ...

Date : 31/08/2009

Among their derivative products are the free ESC Pocket Guidelines App, which provides more than 100 interactive tools to help apply the guidelines in daily practice, and Essential Messages and ...

Date : 02/12/2015

Patients had a transthoracic echocardiogram to assess whether they had structural heart disease (ventricular hypertrophy, systolic or diastolic dysfunction, or pulmonary hypertension). Patients with ...

Date : 11/12/2013

The off-label use of sildenafil in the treatment of residual hypertension in patients with valvular heart disease leads to worse clinical outcomes including a doubled risk of hospitalisation compared ...

Date : 29/08/2017

The document was written jointly by the ESC and the ERS and incorporates evidence accumulated since the previous joint guidelines were published in 2009.3 Pulmonary hypertension is a condition in ...

Date : 29/08/2015